Polyoxometalate inhibition of SOX2-mediated tamoxifen resistance in breast cancer
Abstract Background Increased cancer stem cell (CSC) content and SOX2 overexpression are common features in the development of resistance to therapy in hormone-dependent breast cancer, which remains an important clinical challenge. SOX2 has potential as biomarker of resistance to treatment and as th...
Gorde:
| Egile Nagusiak: | , , , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMC
2024-09-01
|
| Saila: | Cell Communication and Signaling |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1186/s12964-024-01800-w |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|